BOTOX Prophylaxis in Patients With Chronic Migraine

Trial Profile

BOTOX Prophylaxis in Patients With Chronic Migraine

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine
  • Focus Adverse reactions
  • Sponsors Allergan
  • Most Recent Events

    • 27 Jun 2017 Results (n=1160) presented at the 3rd Congress of the European Academy of Neurology.
    • 21 Apr 2016 Results of an Interim Analysis presented at the 68th Annual Meeting of the American Academy of Neurology
    • 13 May 2015 Planned End Date changed from 1 May 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top